GLP-(Survodutide) (10mg)

Survodutide (Glucagon / GLP-1 Receptor Dual-Agonist)

Molecular Formula: C₁₉₂H₂₈₉N₄₇O₆₁ (approximate) Wikipedia
Molecular Weight: ~4,900 g/mol (approximate)
Sequence: [Specify if known or leave blank for catalog entry]
CAS Number: 2805997-46-8 Wikipedia+1
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: Store at −20 °C. Protect from light and moisture.

Description

Survodutide is a synthetic long-acting peptide that simultaneously activates the GLP-1 (glucagon-like peptide-1) receptor and the glucagon (GCGR) receptor. Zealand Pharma+2PMC+2
This dual receptor-agonist mechanism is engineered to combine the appetite-suppression and insulin-modulating effects of GLP-1 activation with the energy-expenditure and hepatic-fat-metabolism effects of glucagon receptor activation. dom-pubs.onlinelibrary.wiley.com+1
The compound has been advanced in clinical trials for investigator research into obesity, metabolic dysfunction-associated steatohepatitis (MASH), and other metabolism-related endpoints. Zealand Pharma+1

Intended Use

This product is intended for laboratory research use only.
It is not for human consumption, diagnostic, or therapeutic use.
All handling should be performed by qualified professionals in a controlled research environment.

Key Research Applications

• Investigation of dual GLP-1/GCGR receptor co-activation and metabolic pathway modulation

• Studies on body‐weight regulation, adiposity reduction, and energy expenditure

• Research on hepatic fat reduction, liver fibrosis markers, and MASH models

• Analysis of peptide receptor interactions in glucose homeostasis, lipid metabolism, and appetite regulation